Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19937354 | 0.92 | GAA (0.42) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL30595298 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL12382052 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL6905751 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL755468 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL30595294 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| Hydrochloric Acid SCHEMBL5504535 | 0.91 | SMN1; SMN2 (0.49) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL316372 | 0.91 | SMN1; SMN2 (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL18432892 | 0.88 | NAAA (0.42) | NAAASMN1; SMN2GAAMEN1KMT2A | |
| SCHEMBL26083006 | 0.88 | NAAA (0.42) | NAAASMN1; SMN2GAAHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3327103-A1 | LIQUID CRYSTAL MEDIUM, METHOD FOR THE STABILISATION THEREOF AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2018-05-30 | — | — | EP | disclosed |
| EP-3327102-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2018-05-30 | — | — | EP | disclosed |